Clinical Trial Update: Prophylactic or Preemptive Entecavir in Patients With Colorectal Cancer Who Are Inactive Hepatitis B Carriers [Phase 2]

View source ↗

Summary

Phase 2 trial update examining prophylactic or preemptive entecavir in colorectal cancer patients who are inactive hepatitis B carriers.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Hepatitis B

Drugs mentioned

• ENTECAVIR (ENTECAVIR)

Snippet

Sponsor: Sun Yat-sen University | Conditions: Colorectal Neoplasms | Phase 2 | Status: UNKNOWN